Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-04-003075
Filing Date
2004-03-16
Accepted
2004-03-16 17:20:54
Documents
13
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 v02088_10k.txt 10-K 382985
3 v02088_ex3-b.txt EX-3.(B) 41249
4 v02088_ex10-b2.txt EX-10.(B)(2) 51784
5 v02088_ex10-h1.txt EX-10.(H)(1) 30786
6 v02088_ex10-s.txt EX-10.(S) 32603
7 v02088_ex14-a.txt EX-14.(A) 4443
8 v02088_ex21-a.txt EX-21.(A) 219
9 v02088_ex23.txt EX-23.(A) 616
10 v02088_ex31-a.txt EX-31.(A) 3794
11 v02088_ex31-b.txt EX-31.(B) 3859
12 v02088_ex32-a.txt EX-32.(A) 1846
13 v02088_ex32-b.txt EX-32.(B) 1900
14 v02088_ex99-a.txt EX-99.(A) 16671
  Complete submission text file 0001144204-04-003075.txt   575425
Mailing Address 25 UPTON DRIVE WILMINGTON MA 01887
Business Address 25 UPTON DRIVE WILMINGTON MA 01887 9786577500
DUSA PHARMACEUTICALS INC (Filer) CIK: 0000879993 (see all company filings)

EIN.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31533 | Film No.: 04673503
SIC: 2834 Pharmaceutical Preparations